Skip to main content

Table 1 Study outcomes

From: Effectiveness of a brief psychological mindfulness-based intervention for the treatment of depression in primary care: study protocol for a randomized controlled clinical trial

Instruments Assessment Area Time of assessmenta
Sociodemographic Gender, age, marital status, education, occupation, economical level. Screening
MINI Psychiatric diagnosis Screening
PHQ-9 Severity of depression Screening, post-module, post-treatment and follow-ups
CSRI Health and social services use Screening and 12-month follow-up
BDI-II Severity of depression Baseline, post-treatment and follow-ups
SF-12 Health-related quality of life Baseline, post-treatment and follow-ups
EQ-5D Health-related quality of life Baseline and follow-ups
PANAS Positive and negative Affect Baseline, post-modules and follow-ups
FFMQ Facets and factors of mindfulness Baseline and follow-ups
PHI Remembered and experienced well-being Baseline and follow-ups
ETS Treatment expectations Baseline
OTS Treatment opinions Post-treatment
  1. MINI Mini-International Neuropsychiatric Interview, PHQ-9 Patient Health Questionnaire-9, CSRI Client Service Receipt Inventory, BDI-II Beck Depression Inventory-II, SF-12 Short Form-12 Health Survey, EQ-5D EuroQoL-5D Questionnaire, PANAS Positive and Negative Affect Scale, FFMQ Five Facet Mindfulness Questionnaire, PHI Pemberton Happiness Index, ETS Expectation of Treatment Scale, OTS Opinion of Treatment Scale.
  2. aWaves: screening, baseline, post-treatment (6 weeks for the “face-to-face MBI + TAU” and “TAU alone” or 12 weeks after baseline for the “Internet-delivered MBI + TAU”), post-module (after each individual module for the “face-to-face MBI + TAU” and for the “Internet-delivered MBI + TAU”), follow-ups (both 6 and 12 month follow-up measurements)